PureTech Health announces first patient dosing in Celea phase 3 trial
13th Jul 2026 10:17
(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More
| Price | 117.60p on 21-08-2026 at 18:35:08 |
|---|---|
| Change | 0.80p 0.68% |
| Buy | 117.40p |
| Sell | 117.00p |
| Last Trade: | Sell 299,665.00 at 117.60p |
| Day's Volume: | 497,909 |
| Last Close: | 117.60p |
| Open: | 117.60p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 116.00p - 117.60p |
| 52wk Range: | 104.80p - 142.80p |
| Market Capitalisation: | £286.26m |
| VWAP: | 117.33705p |
| Shares in Issue: | 243.42m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 299,665 | 117.60p | Uncrossing Trade |
16:35:05 - 21-Aug-26 |
| Sell* | 661 | 117.00p | Automatic Execution |
16:25:31 - 21-Aug-26 |
| Sell* | 2 | 117.20p | Automatic Execution |
16:20:30 - 21-Aug-26 |
| Sell* | 82 | 117.20p | Automatic Execution |
16:20:17 - 21-Aug-26 |
| Sell* | 15 | 117.20p | Automatic Execution |
16:14:11 - 21-Aug-26 |
| Sell* | 212 | 117.20p | Automatic Execution |
16:14:11 - 21-Aug-26 |
| Sell* | 224 | 117.20p | Automatic Execution |
16:14:11 - 21-Aug-26 |
| Sell* | 136 | 117.20p | Automatic Execution |
16:14:11 - 21-Aug-26 |
| Sell* | 1,143 | 117.40p | Automatic Execution |
16:02:59 - 21-Aug-26 |
| Unknown* | 0 | 117.80p | SI Trade |
15:57:44 - 21-Aug-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Aug 2026 5:30 pm | RNS | PDMR Notification RSU Vesting |
| 3rd Aug 2026 7:00 am | RNS | Total Voting Rights |
| 31st Jul 2026 5:00 pm | RNS | PDMR Notification RSU Vesting |
| 17th Jul 2026 5:00 pm | RNS | PDMR Notification RSU Vesting |
| 13th Jul 2026 7:00 am | RNS | PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial |
| 9th Jul 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 2nd Jul 2026 7:01 am | RNS | PRTC Launches Celea w/ $180M & Top Tier Syndicate |
| 2nd Jul 2026 7:00 am | RNS | PRTC Launches Celea: $180M & Asset Transfer |
| 10th Jun 2026 5:38 pm | RNS | Result of AGM |
| 9th Jun 2026 7:00 am | RNS-R | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data |